Related Experiment Video

Updated: Feb 11, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

[Heart failure in elderly women. How to treat?]

Sławomir Chomik, Piotr Hoffman

    Przeglad Lekarski
    |April 20, 2018
    PubMed

    Insights

    Heart failure (HF) disproportionately affects women, particularly older adults. Current clinical research often excludes elderly women, leaving significant gaps in understanding HF treatment efficacy and safety for this demographic.

    Area of Science:

    • Cardiology
    • Geriatrics
    • Women's Health

    Background:

    • Cardiovascular disease is the primary cause of death for women in developed nations.
    • Heart failure (HF) accounts for nearly one-third of cardiovascular deaths, with prevalence increasing significantly with age.
    • Women constitute the majority of HF patients, a proportion expected to rise due to longer life expectancy.

    Purpose of the Study:

    • To highlight the under-representation of women, especially elderly women with HF, in clinical studies.
    • To underscore the lack of data regarding the efficacy and safety of HF treatments in this growing demographic.

    Main Methods:

    • Review of existing literature on HF prevalence and clinical trial participation.
    • Analysis of demographic trends in cardiovascular disease and heart failure.

    Main Results:

    • Elderly women with HF are often excluded from clinical trials due to higher comorbidity rates.
    • This exclusion leads to substantial uncertainty regarding the effectiveness and safety of HF treatments in this population.

    Conclusions:

    • There is a critical need to address the under-representation of elderly women in HF clinical research.
    • Future studies should focus on including this demographic to ensure evidence-based treatment guidelines for all patients.

    More Related Videos

    Gene Transfer for Ischemic Heart Failure in a Preclinical Model07:35

    Gene Transfer for Ischemic Heart Failure in a Preclinical Model

    Published on: May 15, 2011

    13.4K
    Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

    Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

    Published on: July 12, 2024

    1.2K

    Related Concept Videos

    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    1.0K
    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    4.0K
    Heart Failure I: Introduction01:27

    Heart Failure I: Introduction

    Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
    951
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    395
    Heart Failure Drugs: Diuretics01:22

    Heart Failure Drugs: Diuretics

    Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
    1.0K
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    360